Information Provided By: 
Fly News Breaks for February 11, 2020
AYX
Feb 11, 2020 | 09:19 EDT
Needham analyst Jack Andrews raised his price target on Alteryx to $151 and kept his Buy rating ahead of its Q4 results. The analyst believes that the increased pricing of its Server product announced in January should drive another year of strong growth, and while he does not expect that announcement to be reflected in Q4, he sees "relatively higher upfront revenue recognition requirements" boosting the print for the quarter. Andrews adds that the self-service tools offered by Alteryx support a "pivotal function in the Big Data software stack".
News For AYX From the Last 2 Days
AYX
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
